Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients

International Review of Psychiatry

Volumn 21, Issue 4, 2009, Pages 414-423

  Silverstone, Peter H ^a   McGrath, Brent M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; INOSITOL; INOSITOL PHOSPHATE; LITHIUM; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; EPILEPSY; HUMAN; HYPOMANIA; MANIA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER;

AFFECT; ANIMALS; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; HUMANS; INOSITOL; LITHIUM CARBONATE; MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE VALUES; SECOND MESSENGER SYSTEMS; TREATMENT OUTCOME; UBIQUITIN-PROTEIN LIGASES; VALPROIC ACID;

EID: 70350649053     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260902962214     Document Type: Review

References (56)

1. Asghar, S. J., Tanay, V. A. M. I., Baker, G. B., Greenshaw, A., Silverstone, P. H. (2003). Poor relationship of plasma amphetamine levels to physiologic, subjective, cognitive and biochemical measures in healthy volunteers. Human Psychopharmacology, 18, 291-299.
2. Berridge, M. J., Downes, C. P., & Hanley, M. R. (1982). Lithium amplifies agonist-dependent phosphatidyl-inositol responses in brain and salivary glands. Biochemical Journal, 206, 587-595.
3. Berridge, M. J., & Irvine, R. F. (1989). Inositol phosphates and cell signaling. Nature, 341, 197-204.
4. Brambilla, P., Stanley, J. A., Sassi, R. B., Nicoletti, M. A., Mallinger, A. G., Keshavan, M. S., & Soares, J. C. (2004). 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology, 29, 1918-1924.
5. Bruhn, H., Stoppe, G., Staedt, J., Merboldt, K. D., Hänicke, W., & Frahm, J., (1993). Quantitative proton MRS in vivo shows cerebral myo-inositol and cholines to be unchanged in manicdepressive patients treated with lithium [abstract]. 12th Annual Scientific Meeting, New York, August 14-20, 1993. Proceedings of the Society of Magnetic Resonance Med Annual Meeting, pp. 1543.
6. Cecil, K. M., DelBello, M. P., Moray, R., Strakowski, S. M. (2002). Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorder, 4, 357-365.
7. Chang, K., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., & Ketter, T. (2003). Decreased N-acetylaspartate in children and familial bipolar disorder. Biological Psychiatry, 53, 1059-1065.
8. Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K. et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry, 61, 450-458.
9. Deicken, R. F., Fein, G., & Weiner, M. W. (1995a). Abnormal frontal lobe phosphorus metabolism in bipolar disorder. American Journal of Psychiatry, 152, 915-918.
10. Deicken, R. F., Weiner, M. W., & Fein, G. (1995b). Decreased temporal lobe phosphomonoesters in bipolar disorder. Journal of Affective Disorder, 33, 198-199.
11. Diehl, D. J., & Gershon, S. (1992). The role of dopamine in mood disorders. Comprehensive Psychiatry, 33, 115-120.
12. Frey, R., Metzler, D., Fischer, P., Heiden, A., Scharfetter, J., Moser, E., Kasper, S. (1998). Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. Journal of Psychiatric Research, 32, 411-420 .
13. Friedman, S. D., Dager, S. R., Parow, A., Hirashima, F., Demopulos, C., Stoll, A. L. et al. (2004). Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biological Psychiatry, 56, 340-348. (Pubitemid 39164519)
14. Frye, M. A., Watzl, J., Banakar, S., O'Neill, J., Mintz, J., Davanzo, P. et al. (2007a). Increased anterior cingulate/ medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology, 32, 2490-2499.
15. Frye, M. A., Thomas, M. A., Yue, K., Binesh, N., Davanzo, P., Ventura, J. et al. (2007b). Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: A study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Research, 154, 259-265.
16. Godfrey, P. P., McCkye, S. J., White, A. M., Wood, A. J., & Grahame-Smith, D. G. (1989). Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoridestimulated inositol phosphate production in rat cortex. Journal of Neurochemistry, 52, 498-506.
17. Hallcher, L. M., & Sherman, W. R. (1980). The effect of lithium ion and other agents on the activity of myo-inositol- 1-phosphatase from bovine brain. Journal of Biological Chemistry, 255, 10896-10901.
18. Hamakawa, H., Murashita, J., Yamada, N., Inubushi, T., Kato, N., & Kato, T. (2004). Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Neuroscience of Clinical Psychiatry, 58, 82-88.
19. Hirvonen, M. R. (1991). Cerebral lithium, inositol and inositol monophosphates. Pharmacology & Toxicology, 69, 22-27.
20. Jacobs, D., Silverstone, T. (1986). Dextroamphetamine induced arousal in human subjects as a model for mania. Psychological Medicine, 16, 323-329.
21. Kato, T., Shioiri, T., Takahashi, S., & Inubushi, T. (1991). Measurement of brain phosphoinositide metabolism in biplolar patients using in vivo 31P MRS. Journal of Affective Disorder, 22, 185-190.
22. Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1992). Brain phosphorus metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorder, 26, 223-230.
23. Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1993). Alterations in brain phosphorus metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. Journal of Affective Disorder, 27, 53-59.
24. Kato, T., Shioiri, T., Murashita, J., Hamakawa, H., Inubushi, T., & Takahashi, S. (1994a). Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatric Research: Neuroimaging, 55, 41-50. (Pubitemid 24119048)
25. Kato, T., Takahashi, S., Shioiri, T., Murashita, J., Hamakawa, H., & Inubushi, T. (1994b). Reductions of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorder, 31, 125-133. (Pubitemid 24183900)
26. Kato, T., Shioiri, T., Murashita, J., Hamakawa, H., Takahashi, Y., Inubushi, T., & Takahashi, S. (1995). Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychological Medicine, 25, 557-566.
27. Kato, T., Murashita, J., Kamiya, A., Shioiri, T., Kato, N., & Inubushi, T. (1998). Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: A confirmation in drug-free patients and correlation with white matter hyperintensity. European Archives of Psychiatric and Clinical Neuroscience, 248, 301-306.
28. Kim, H., McGrath, B. M., & Silverstone, P. H. (2005). A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders - focus on magnetic resonance spectroscopy (MRS) studies. Human Psychopharmacology, 20, 309-326.
29. Majerus, P. W., Connolly, T. M., Bansal, V. S., Inhorn, R. C., Ross, T. S., & Lips, D. L. (1988). Inositol phosphates: Synthesis and degradation. Journal of Biological Chemistry, 263, 3051-3054.
30. Masand, P. S. & Tesar, G. E. (1996). Use of stimulants in the medically ill. Psychiatric Clinics of North America, 19, 515-547.
31. McGrath, B. M., McKay, R., Dave, S., Seres, P., Weljie, A. M., Slupsky, C. M. et al. (2008). Acute dextroamphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3T and 18.8T. Neuroscience Research, in press.
32. Moore, G. J., Bebchuk, J. M., Parrish, J. K., Faulk, M. W., Arfken, C. L., Strahl-Bevacqua, J., & Manji, H. K. (1999). Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manicdepressive illness. American Journal of Psychiatry, 156, 1902-1908.
33. Moore, G. J., Breeze, J., Gruber, S. A., Babb, S. M., Frederic B. de, B. et al. (2000). Choline, myo-inositol and mood in bipolar disorder: A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disorder, 2, 207-216.
34. Murashita, J., Kato, T., Shioiri, T., Inubushi, T., & Kato, N. (2000). Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy. Psychological Medicine, 30, 107-115.
35. O'Donnell, T., Rotzinger, S., Nakashima, T. T., Hanstock, C. C., Ulrich, M., & Silverstone, P. (2000). Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain. Brain Research, 880, 84-91.
36. Öngur, D., Jensen, J. E., Prescot, A. P., Stork, C., Lundy, M., Cohn, B. M., & Renshaw, P. J. (2008). Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biological Psychiatry, 16, 718-726.
37. Patel, N. C., DelBello, M. P., Cecil, K. M., Adler, C. M., Bryan, H. S., Stanford, K. E., Strakowski, S. M. (2006). Lithium treatment effects on myo-inositol in adolescents with bipolar depression. Biological Psychiatry, 60, 998-1004.
38. Preece, N. E., Gadian, D. G., Houseman, J., & Williams, S. R. (1992). Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: A multinuclear magnetic resonance study in vivo. Lithium, 3, 287-297.
39. Renshaw, P. F., Summers, J. J., Renshaw, C. E., Hines, K. G., & Leigh, J. S. (1986). Changes in the 31P-NMR spectra of cats receiving lithium chloride systematically. Biological Psychiatry, 21, 694-698.
40. Scherk, H., Backens, M., Schneider-Axmann, T., Usher, J., Kemmer, C., Reith, W., Falkai, P., & Gruber, O. (2007). Cortical neurochemistry in euthymic patients with bipolar I disorder. World Journal of Biological Psychiatry, 1-10.
41. Sharma, R., Venkatasubramanian, P. N., Barany, M., & Davis, J. M. (1992). Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research, 8, 43-49.
42. Sherman, W. R., Munsell, L. Y., Gish, B. G., & Honchar, M. P. (1985). Effects of systematically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis. Journal of Neurochemistry, 44, 798-807.
43. Silverstone, P. H., Hanstock, C. C., Fabian, J., Staab, R., & Allen, P. S. (1996). Chronic lithium does not alter human myoinositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biological Psychiatry, 40, 235-246.
44. Silverstone, P. H., Rotzinger, S., Pukhovsky, A., & Hanstock, C. C. (1999). Effects of lithium and amphetamine on inositol metabolism in human brain as measured by 1H and 31P MRS. Biological Psychiatry, 46, 1634-1641.
45. Silverstone, P. H., Asghar, S. J., O'Donnell, T., Ulrich, M., & Hanstock, C. C. (2004). Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. World Journal of Biological Psychiatry, 5, 38-44. (Pubitemid 44121726)
46. Silverstone, P. H., Pukhovsky, A., & Rotzinger, S. (1998). Lithium does not attenuate the effects of dextroamphetamine in healthy volunteers. Psychiatry Research, 79, 219-226.
47. Silverstone, T., Wells, B., & Trenchard, E. (1983). Differential dose-response effects of dexamphetamine sulphate on hunger, arousal and mood in human volunteers. Psychopharmacology, 79, 242-245.
48. Silverstone, P. H., Wu, R. H., O'Donnell, T., Ulrich, M., Asghar, S. J., & Hanstock, C. C. (2002). Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Human Psychopharmacology Clinical and Experimental, 17, 321-327.
49. Simister, R. J., McLean, M. A., Barker, G. J., & Duncan, J. S. (2003). Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology, 61, 897-902.
50. Simister, R. J., McLean, M. A., Barker, G. J., & Duncan, J. S. (2007). The effect of sodium valproate on proton MRS visible neurochemical concentrations. Epilepsy Research, 74, 215-219.
51. Strange, K., Morrison, R., Heilig, C. W., DiPietro, S., & Gullans, S. R. (1991). Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells. American Journal of Physiology, 260, C784-C790.
52. Sun, G. Y., Navidi, M., Yoa, F. G., Lin, T. N., Orth, O. E., Stubbs, E. B., & MacQuarrie, R. A. (1992). Lithium effects on inositol phospholipids and inositol phosphates: Evaluation of an in vivo model for assessing polyphosphoinositide turnover in brain. Journal of Neurochemistry, 58, 290-297.
53. Vadnal, R., & Parthasarathy, R. (1995). Myo-inositol monophosphatase: Diverse effects of lithium, carbamazepine, and valproate. Neuropsychopharmacology, 12, 277-285.
54. Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2000). Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biological Psychiatry, 47, 475-481.
55. Wu, R. H., O'Donnell, T., Ulrich, M., Asghar, S. J., Hanstock, C. C., & Silverstone, P. H. (2004). Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Annals of General Hospital Psychiatry, 3, 13.
56. Yuldiz, A., Sachs, G. S., Dorer, D. J., & Renshaw, P. F. (2001). 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: A meta-analysis. Psychiatric Research: Neuroimaging sect, 106, 181-191.